  |
 | Up a level |
Cherney, David Z.I. and Cosentino, Francesco and Dagogo-Jack, Samuel and McGuire, Darren K. and Pratley, Richard and Frederich, Robert and Maldonado, Mario and Liu, Chih-Chin and Liu, Jie and Pong, Annpey and Cannon, Christopher P. and Ukraine: and Godlevska, Olga and Chopey, Ivan and Teliatnikova, Zinaida and Kuskalo, Petro and Abrahamovych, Orest and Mankovskyi, Borys and Fushtey, Ivan and Myshanych, Galyna and Tykhonova, Susanna and Tseluyko, Vira and Koval, Olena and Parkhomenko, Oleksandr and Prokhorov, Oleksandr and Vayda, Myroslava and Martymianova, Larysa and Zharinova, Viktoriia and Prystupa, Lyudmyla and Pererva, Larysa and Kovalov, Oleksandr and Sokolova, Lyubov and Botsyurko, Volodymyr and Maslyanko, Vitaliy and Vlasenko, Maryna and Khomazyuk, Tetyana and Kulyk, Anna and Synenko, Volodymyr and Karpenko, Oleksandr and Mostovoy, Yuriy and Gyrina, Olga and Dolzhenko, Maryna and Donets, Oleksandra and Sorokina, Inna and Malynovsky, Yaroslav and Lysunets, Olena and Petrovskyy, Roman and Panina, Svitlana (2021) Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial. Clinical Journal of the American Society of Nephrology = CJASN, vol.16 (no. 9). pp. 1345-1354. ISSN 1555-9041 (Print), 1555-905X (Online)
Cherney, David Z.I. and McGuire, Darren K. and Charbonnel, Bernard and Cosentino, Francesco and Pratley, Richard and Dagogo-Jack, Samuel and Frederich, Robert and Maldonado, Mario and Liu, Jie and Pong, Annpey and Liu, Chih-Chin and Cannon, Christopher P. and On behalf of the VERTIS CV Investigators and Ukraine: and Koval, Olena and Khomazyuk, Tetyana and Panina, Svitlana (2021) Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function Observations From VERTIS CV. Circulation, 143. pp. 602-605. ISSN 0009-7322 (Print), 1524-4539 (Online)
Cherney, David Z. I. and Dagogo-Jack, Samuel and McGuire, Darren K. and Cosentino, Francesco and Pratley, Richard and Shih, Weichung J. and Frederich, Robert and Maldonado, Mario and Liu, Jie and Wang, Shuai and Cannon, Christopher P. and on behalf of the VERTIS CV Investigators and Ukraine: and Koval, Olena and Khomazyuk, Tetyana and Panina, Svitlana (2021) Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials. Clinical Cardiology, 44 (8). pp. 1139-1143. ISSN 1932-8737 (Online)
Perkovic, V. and Jardine, M. J. and Neal, B. and Bompoint, S. and Heerspink, H. J. L. and Charytan, D. M. and Edwards, R. and Agarwal, R. and Bakris, G. and Bull, S. and Cannon, C.P. and Capuano, G. and Chu, P.-L. and de Zeeuw, D. and Greene, T. and Levin, A. and Pollock, C. and Wheeler, D.C. and Yavin, Y. and Zhang, H. and Zinman, B. and Meininger, G. and Brenner, B.M. and Mahaffey, K.W. and Ukraine: and Kolesnyk, Mykola and Barna, Olga and Bilyk, Svitlana D. and Botsyurko, Volodymyr and Dudar, Iryna and Fushtey, Ivan and Godlevska, Olga and Golovchenko, Oleksandr and Gyrina, Olga and Kazmirchuk, Anatoliy and Komisarenko, Iuliia and Korzh, Oleksii and Kravchun, Nonna and Legun, Oleg and Mankovskyy, Borys and Martynyuk, Liliya and Mostovoy, Yuriy and Pashkovska, Nataliia and Pererva, Larysa and Pertseva, Tetyana and Samoylov, Oleksandr and Smirnov, Ivan and Svyshchenko, Yevgeniya and Tomashkevych, Halyna and Topchii, Ivan and Tryshchuk, Nadiya and Tseluyko, Vira and Vizir, Vadym and Vlasenko, Maryna and Zlova, Tetiana and Zub, Liliia (2019) Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. The New England Journal of Medicine = N Engl J Med, 380 (24). pp. 2295-2306. ISSN 0028-4793 (print); 1533-4406 (online)
Wiviott, S.D. and Raz, I. and Bonaca, M.P. and Mosenzon, O. and Kato, E.T. and Cahn, A. and Silverman, M.G. and Zelniker, T.A. and Kuder, J.F. and Murphy, S.A. and Bhatt, D.L. and Leiter, L.A. and McGuire, D.K. and Wilding, J.P.H. and Ruff, C.T. and Gause‑Nilsson, I.A.M. and Fredriksson, M. and Johansson, P.A. and Langkilde, A.-M. and Sabatine, M.S. and for the DECLARE–TIMI 58 Investigators* and Ukraine: and Karpenko, O. and Tkach, S. and Vlasenko, M. and Fushtey, I. and Pertseva, T. and Reshotko, D. and Mostovoy, Y. and Vizir, V. and Kraiz, I. and Amosova, K. and Batushkin, V. and Tseluyko, V. and Koval, O. (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes. The New England Journal of Medicine = N Engl J Med, 380 (4). pp. 347-357. ISSN 0028-4793 (print); 1533-4406 (online)
Cannon, Christopher P. and McGuire, Darren K. and Pratley, Richard and Dagogo-Jack, Sam and Mancuso, James and Huyck, Susan and Charbonnel, Bernard and Shih, Weichung J. and Gallo, Silvina and Masiukiewicz, Urszula and Golm, Gregory and Cosentino, Francesco and Lauring, Brett and Terra, Steven G. and on behalf of the VERTIS-CV, Investigators and Ukraine: and Godlevska, Olga and Chopey, Ivan and Teliatnikova, Zinaida and Kuskalo, Petro and Abrahamovych, Orest and Mankovskyi, Borys and Fushtey, Ivan and Myshanych, Galyna and Tykhonova, Susanna and Tseluyko, Vira and Koval, Olena and Parkhomenko, Oleksandr and Prokhorov, Oleksandr and Vayda, Myroslava and Martymianova, Larysa and Zharinova, Viktoriia and Prystupa, Lyudmyla and Pererva, Larysa and Kovalov, Oleksandr and Sokolova, Lyubov and Botsyurko, Volodymyr and Maslyanko, Vitaliy and Vlasenko, Maryna and Khomazyuk, Tetyana and Kulyk, Anna and Synenko, Volodymyr and Karpenko, Oleksandr and Mostovoy, Yuriy and Gyrina, Olga and Dolzhenko, Maryna and Donets, Oleksandra and Sorokina, Inna and Malynovsky, Yaroslav and Lysunets, Olena and Petrovskyy, Roman and Panina, Svitlana (2018) Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). American Heart Journal, 206. pp. 11-23. ISSN 0002-8703 (Print), 1097-6744 (Online)
Fulcher, G. and Matthews, D.R. and Perkovic, V. and de Zeeuw, D. and Mahaffey, K.W. and Mathieu, C. and Woo, V. and Wysham, C. and Capuano, G. and Desai, M. and Shaw, W. and Vercruysse, F. and Meininger, G. and Neal, B. and CANVAS trial collaborative group and Ukraine: and Larin, Oleksandr and Panina, Svetlana and Popik, Galyna and Kovalenko, Svitlana and Voloshyna, Olena and Tseluyko, Vera and Gyrina, Olga and Vizir, Vadim and Barna, Olga and Dolzhenko, Maryna and Ignatenko, Grigoriy and Mostovoy, Yuriy and Korpachev, Vadim and Mankovskiy, Boris and Vatutin, Mykola (2016) Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 18 (1). pp. 82-91. ISSN 1462-8902 (Print), 1463-1326 (Online)
